The latest advancements in elbow disease management

Video

In this dvm360® interview, Dr Matthew Brunke, describes how Synovetin OA has proved to be a beneficial modality

According to Matthew Brunke, DVM, DACVSMR, CCRP, CVPP, CVA, faculty for the Directions in Veterinary Medicine (DIVM) symposium in Miami, Florida, there are currently no available treatments for elbow disease, however there are therapies for managing it. In a dvm360® interview, he shares how Synoventin OA serves as an effective option based on research and personal experience.

Register today for the Directions in Veterinary Medicine symposium in Miami, Florida taking place May 19-20, 2023.

The following is a partial transcript of the video.

Matthew Brunke, DVM, DACVSMR, CCRP, CVPP, CVA: [Synovetin OA] is nuclear, though, so it's a little bit different. It's using new medical radioisotopes and nuclear medicine. So that may scare off some people, but it's really worth looking at. It's been by far and away my favorite thing to use for elbow arthritis, having used a lot of other modalities. And this is where we're not only seeing the best results, but the most long-lasting ones.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.